Skip to content

Drug interactions

Glecaprevir / pibrentasvir + Imatinib

Severity: Moderate

Glecaprevir / pibrentasvir and Imatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glecaprevir and pibrentasvir inhibit P-glycoprotein, BCRP and OATP transporters and may increase imatinib exposure. Imatinib could also modestly raise glecaprevir levels via CYP3A4 inhibition. Clinical significance is likely modest but increased imatinib adverse effects are possible.

What this interaction means in plain words

Glecaprevir / pibrentasvir and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Inhibition of P-gp/BCRP/OATP transport by glecaprevir/pibrentasvir increases imatinib exposure, and imatinib inhibits CYP3A4.

What to do

Monitor for imatinib adverse effects such as edema, cytopenias and liver enzyme elevation, and for hepatic tolerability during HCV therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glecaprevir / pibrentasvir and Imatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Glecaprevir / pibrentasvir with Imatinib?

MediHelp rates the interaction as moderate. Glecaprevir / pibrentasvir and Imatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glecaprevir and pibrentasvir inhibit P-glycoprotein, BCRP and OATP transporters and may increase imatinib exposure. Imatinib could also modestly raise glecaprevir levels via CYP3A4 inhibition. Clinical significance is likely modest but increased imatinib adverse effects are possible.

How serious is the interaction between Glecaprevir / pibrentasvir and Imatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for imatinib adverse effects such as edema, cytopenias and liver enzyme elevation, and for hepatic tolerability during HCV therapy.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in